Johnson & Johnson is about to test an experimental HIV vaccine on thousands of people
Johnson & Johnson is preparing to test an experimental HIV vaccine in the United States and Europe in a move toward developing the first immunization against the deadly disease after decades of frustration. Read Article
Best Academic Research Team, Vaccine Industry Excellence Award, World Vaccine Congress 2019
Dr. Dan Barouch accepts the Best Academic Research Team, Vaccine Industry Excellence Award, World Vaccine Congress 2019 in Washington D.C., on April 15th 2019
A New Weapon Against HIV
Dr.Barouch spoke to Discover Magazine about a promising candidate for an HIV vaccine raises hopes. Read Article
HIV Vaccines with Dan Barouch
Dr. Dan Barouch discusses the challenges in designing an HIV vaccine and the ongoing clinical trials with vaccine research at BIDMC.
[Podcast]
NIH Statement on World AIDS Day
“We are optimistic that an end to the HIV pandemic is feasible. However, to reach this goal, we must apply the tools and advances already at hand as we continue to follow the science in laboratories and clinics around the world. Today we honor the achievements of dedicated researchers, health care professionals, clinical trial participants and members of the global community, and we reaffirm our commitment to work together to fill the remaining gaps. [NIH news]
HIV vaccine on horizon as jab triggers immunity in humans and stops monkeys being infected
“We eagerly await the results of the phase 2b Imbokodo’, which will determine whether or not this vaccine will protect humans against acquiring HIV.”
